Kdt Advisors LLC Q2 2026 Portfolio Activity: Focus on Technology, Healthcare Growth

As reported for the period ending June 30, 2026, Kdt Advisors LLC's portfolio saw specific changes in holdings. The investment firm adjusted its positions across various sectors and also established new holdings.

Kdt Advisors LLC demonstrated a continued focus on Technology stocks, particularly through adjustments to its Vanguard ETF holdings. The fund's largest position increased slightly with VANGUARD INDEX FUND SHARES (VOO), which saw an increase of 477 shares (+3.32%). This adjustment maintained VOO at approximately 14% allocation.

Additionally, the Technology sector gained further prominence via new positions in two Vanguard funds: VANGUARD INDEX FUND SHARES (VTI), which was added entirely this quarter with a 740 share increase (+22.02%), and the highly significant addition of shares to VANGUARD INDEX FUNDS (VOO) itself, boosting its allocation from previous levels.

In the Healthcare sector, Kdt Advisors LLC significantly increased its stake in ABBOTT LABORATORIES (ABT). The fund added 1439 shares to ABT (+53.96%), raising its portfolio allocation percentage considerably.

Elsewhere, the firm bolstered its Consumer Cyclical exposure through two new positions: LENNAR CORP (LEN-B), which was added entirely this quarter with a 2914 share increase (+100.0%), and the addition of shares to INTERACTIVE BROKERS GROUP IN (IBKR). This latter position saw an increase, suggesting renewed interest in the brokerage.

The firm also disposed of some holdings during Q2 2026. The most notable exit was from SPDR GOLD SHARES (GLD), which experienced a substantial reduction with a decrease of -644 shares (-52.15%). This significantly lowered GLD's allocation percentage.

Furthermore, Kdt Advisors LLC sold some VANGUARD WHITEHALL FUNDS (VYM), reducing its position by 750 shares (-7.97%) and exiting that specific fund entirely if it was previously held.